A return to the fundamentals of drug discovery?
Williams, M.
Current Opinion in Investigational Drugs 5(1): 29-33
2004
ISSN/ISBN: 1472-4472 PMID: 14983970 Document Number: 570952
Document emailed within 1 workday
Related Documents
Kojima, H.; Okabe, T.; Nagano, T. 2013: Open innovation center for drug discovery: a research-supporting network for drug discovery Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 141(6): 327-332Fujita, Y. 2013: Innovation by TaNeDS (Take a New challenge of Drug diScovery) collaborative drug discovery project Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 142(2): 89-95
Shen, Y. 2007: Discovery on Target 2007--CHI's Fifth Annual Conference. RNAi for Drug Discovery and Therapeutics IDrugs: the investigational drugs journal 10(12): 848-850
Young, S.S. 1999: Discovery 99: accelerate and improve the drug discovery process. 26-29 April 1999, San Diego, CA, USA IDrugs: the investigational drugs journal 2(7): 648-649
Kashyap, A.; Singh, P.Kumar.; Silakari, O. 2018: Counting on Fragment Based Drug Design Approach for Drug Discovery Current Topics in Medicinal Chemistry 18(27): 2284-2293
Alhenc-Gelas, Fçois.; Parmentier, L.; Bisagni, A. 2003: Pharmacogenetic and pharmacogenomic studies. Impact on drug discovery and drug development Therapie 58(3): 275-282
Emilien, G.; Maloteaux, J.M. 1998: Pharmacological management of epilepsy. Mechanism of action, pharmacokinetic drug interactions, and new drug discovery possibilities International Journal of Clinical Pharmacology and Therapeutics 36(4): 181-194
Zangl, K. 1995: Fundamentals of oral drug therapy in chronic malignant pain Pflege Zeitschrift 48(4 Suppl): 1-16
Rowan, A.J. 2002: Seizure. Fundamentals of drug management of epilepsy in the older patient Geriatrics 57(9): 33-37; Quiz 38
Armetti, L. 1999: Round table: The Italian Pharmacology Society and the drug industry: new processes in drug discovery and the contribution of universities Bollettino chimico farmaceutico 138(11): 596-598
Bittner, B.; Mountfield, R.J. 2002: Intravenous administration of poorly soluble new drug entities in early drug discovery: the potential impact of formulation on pharmacokinetic parameters Current Opinion in Drug Discovery and Development 5(1): 59-71
Williams, M. 2003: Genome-based drug discovery: prioritizing disease-susceptibility/disease-associated genes as novel drug targets for schizophrenia Current Opinion in Investigational Drugs 4(1): 31-36
1996: Redesigning drug discovery Nature 384(6604 Suppl): 1-5
McGowan, J.; Hoth, D. 1989: AIDS drug discovery and development Journal of Acquired Immune Deficiency Syndromes 2(4): 335-343
Wu, Y-Shan.; Lin, W-Hsing.; Hsu, J.T-A.; Hsieh, H-Pang. 2006: Antiviral drug discovery against SARS-CoV Current Medicinal Chemistry 13(17): 2003-2020
Cárdenas, M.L.; Cornish-Bowden, A. 2000: Metabolic analysis in drug discovery Science 288(5466): 618-619
Bondy, S.S. 1998: The role of automation in drug discovery Current Opinion in Drug Discovery and Development 1(1): 116-119
Murata, M. 2010: Discovery of an antiparkinsonian drug: zonisamide Rinsho Shinkeigaku 50(11): 780-782
Bleicher, K.H. 2002: Chemogenomics: bridging a drug discovery gap Current Medicinal Chemistry 9(23): 2077-2084
Frigeri, A.; Nicchia, G.Paola.; Svelto, M. 2007: Aquaporins as targets for drug discovery Current Pharmaceutical Design 13(23): 2421-2427